Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Ottawa Heart Institute Research: Clinical Trials & FDA Approval Profile

Ottawa Heart Institute Research (Global / Institutional) sponsors 16 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 11 active protocols (10 recruiting now), 4 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)6.3%
Median Closed Enrollment vs National (145 pts)115 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Ottawa Heart Institute Research
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)16
Active Pipeline (Recruiting Now)11 (10)
Completed vs Stopped Early4 / 1 (6.3%)
Median Closed Actual Enrollment115 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Ottawa Heart Institute Research
Hospital Research SiteLocationShared Protocols
Mayo Clinic RochesterRochester, MN2

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Ottawa Heart Institute Research
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT03593759Cardiac Sarcoidosis Randomized TrialPhase IIIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Ottawa Heart Institute Research Interactive Dossier, benchmark peers in Cardiovascular and Thrombosis, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI